Gastroenterology

SORT BY:     Most Recent      Most Viewed
  • March 1, 2000
    PREVIEW

    The late December approval of celecoxib (Celebrex—Searle) for familial adenomatous polyps (FAP) brings with it a third dosage regimen for pharmacists to recognize as appropriate: 400 mg...

Pages